Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	ENHERTU
Active Ingredient:	Trastuzumab deruxtecan 100mg
Dosage Form:	Powder for infusion concentrate
New Zealand Sponsor:	AstraZeneca Limited
Manufacturer:	Simtra Deutschland GmbH, Halle, Germany

*Product:*	Heparin Injection
Active Ingredient:	Heparin sodium 1000IU/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Bridgewest Perth Pharma Pty Limited, Perth, Australia

*Product:*	Heparin Injection
Active Ingredient:	Heparin sodium 5000IU/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Bridgewest Perth Pharma Pty Limited, Perth, Australia

*Product:*	Heparinised Saline Injection
Active Ingredient:	Heparin sodium 10IU/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Bridgewest Perth Pharma Pty Limited, Perth, Australia

*Product:*	Ioscan
Active Ingredient:	Amidotrizoic acid dihydrate 378.65mg/mL
Dosage Form:	Oral solution
New Zealand Sponsor:	DE Healthcare Limited
Manufacturers:	Teradoran Pty Limited t/a Activ Pharmaceuticals, Sydney, Australia Delta Laboratories Pty Limited, Sydney, Australia

*Product:*	Ozempic (2mg/1.5mL)
Active Ingredient:	Semaglutide 1.34mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Novo Nordisk Pharmaceuticals Limited
Manufacturers:	Novo Nordisk A/S, Copenhagen, Denmark Novo Nordisk A/S, Hillerod, Denmark

*Product:*	Ozempic (4mg/3mL)
Active Ingredient:	Semaglutide 1.34mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Novo Nordisk Pharmaceuticals Limited
Manufacturers:	Novo Nordisk A/S, Copenhagen, Denmark Novo Nordisk A/S, Brennum Park, Hillerod, Denmark Novo Nordisk Pharmaceutical Industries LP, North Carolina, United States of America

*Product:*	Polivy
Active Ingredient:	Polatuzumab vedotin 30mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	F Hoffmann-La Roche AG, Kaiseraugst, Switzerland

Product:	Polivy
Active Ingredient:	Polatuzumab vedotin 140mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	BSP Pharmaceuticals SpA, Latina Scalo, Italy

Dated this 10th day of March 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health 11 September 2013).

Tags

Notice Number

Schedule